Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract infection, however,
a subset of patients progress to severe disease and respiratory failure. The mechanism …

These guidelines are a consensus work of a considerable number of members of the
immunology and flow cytometry community. They provide the theory and key practical aspects of …

… Severe systemic symptoms—including fatigue, myalgia, headache, feverishness or chills,
and fever higher than 38C—were most frequently reported after ChAdOx1 nCov-19 prime …

COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…

… 2C), we found a peak in the MAIT-cell response to bacteria between 12–18 h (not shown).
At this early time point, cytokine stimulation was not sufficient to induce IFNγ on its own in most …

Purpose Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide
causing a global health emergency. Pa-COVID-19 aims to provide comprehensive data …

… Patients with mismatch-based risk (seronegative recipient and seropositive donor) for
CMV or EBV as well as patients from arm C received at least a 3 months prophylaxis with …

… Incidence of multifunctional CD4+ triple interferon gamma (IFN-γ)/interleukin (IL)-2/tumor
necrosis factor-alpha (TNF-α) (A) and double IL-2/TNF-α (C) responders and magnitude of total …

… The Tempus™ tube (3 ml) will be shaken, non-centrifugated, incubated for 2 h at room
temperature, and then stored in a freezer (at −20C). One drop of full blood is placed on a dry …